中文
OUR RESEARCH AREA
What's monoclonal antibody (mAB)?
monoclonal antibody (mAB) ?A single type of antibody that is directed against a specific epitope (antigen, antigenic determinant) and is produced by a single clone of B cells or a single hybridoma cell line, which is formed by the fusion of a lymphocyte cell with a myeloma cell. Some myeloma cells synthesize single antibodies naturally.


[2010-2-5] CPGJ Selected to be Intellectual Property Pilot Unit
[2009-12-14] A new chapter in Biopharmaceuticals -The Collaboration between Chinese and Brazilian Pharmaceutical Enterprises
[2009-8-21] CPGJ was awarded the Leader & Contributor of Science and Technology in the 10th Anniversary of Focus in Zhangjiang Selection Activity
[2009-6-23] YISAIPU: Top 10 Innovations
[2009-5-30] Model Unit
[2009-5-12] National Research Centre of Antibody Drugs Settles in Zhangjiang
[2009-3-6] Shen Investigates CPGJ
[2009-1-16] Continuous Innovation, Developing Together
 

[2010-2-23] YISAIPU Won the 11th China's Patent Award
[2008-4-21] Example Project “Industrialization of high technology of humanized monoclonal antibody drug such as Recombinant Human Tumor Necrosis Factor – a Receptor II: IgG Fc Fusion Protein for Injection” passed acceptance check
[2008-1-2] YISAIPU was nominated by Shanghai Federation of Industrial Economics as “2007 brand of independent creation in the Shanghai equipment manufacturing industry and high technology & new technology industry”.
[2007-10-13] The meeting about Project
[2006-12-15] The first export products are transported to Colombia
[2006-11-10] Yisaipu is awarded for “national new crucial product”
[2006-10-8] Xinmeige is cognized the new crucial product in shanghai
[2006-9-20] The packing box of a new product attained for appearance design patent certificate issued by State Intellectual Property Office of PRC.
 

  Copyright 2002-2006 Shanghai CP Guojian Pharmaceutical Co.,Ltd.